On Friday, the U.S. Food and Drug Administration (FDA) approved a new medication to treat acute migraine with or without aura called Reyvow.

Read more here.

Subscribe To Our Weekly Newsletter

Subscribe To Our Weekly Newsletter

Get a weekly digest of our posts straight to your inbox! We promise, no spam ever.

You have Successfully Subscribed!

Pin It on Pinterest

Share This